PNPLA3 and metabolic dysfunction-associated steatotic liver disease: This indicates that the fundamental pathogenic mechanisms in lean individuals, including particular genetic variants (e.g., PNPLA3 GG genotype), which influences NAFLD progression risk (82) and impaired adipose tissue, are sufficiently robust to promote fibrogenesis, regardless of total body fat.